Vesna M. Spasovski - Genetic Mutations

Author Information

Vesna Spasovski is affiliated with the Institute of Molecular Genetics and Genetic Engineering at the University of Belgrade in Belgrade, Serbia. Her research focuses on various genetic and molecular studies, particularly involving inflammatory diseases, stem cell therapy, and genetic profiling.

Research Contributions

Vesna Spasovski has made significant contributions to the field of genetics and molecular biology. Her work covers a wide range of topics including the use of autologous adipose tissue-derived mesenchymal stem cells for treating canine degenerative lumbosacral stenosis, the relevance of gene expression in tuberculosis patients, and the importance of genomic profiling for diagnosing pediatric lung diseases with suspected ciliopathies. Notably, her research also delves into the genetic characterization of glycogen storage disease in the Serbian population and the role of interleukin-6 gene polymorphisms in systemic sclerosis.

Aliases

Vesna M. Spasovski

Publication and Citation Metrics

Metric	Value
Citation Count	452
H-index	14
Paper Count	47

Publications:

Case Report: Successful Therapy of Spontaneously Occurring Canine Degenerative Lumbosacral Stenosis Using Autologous Adipose Tissue-Derived Mesenchymal Stem Cells

DOI: 10.3389/fvets.2021.732073

Year: 2021

Relevance of TNF-α, IL-6 and IRAK1 gene expression for assessing disease severity and therapy effects in tuberculosis patients.

DOI: 10.3855/JIDC.10949

Year: 2019

The importance of genomic profiling for differential diagnosis of pediatric lung disease patients with suspected ciliopathies

DOI: 10.2298/SARH181012012A

Year: 2019

Expression of miRNA-210 in human bone marrow-derived mesenchymal stromal cells under oxygen deprivation

DOI: 10.2298/ABS181117001L

Year: 2019

Genes and metabolic pathway of sarcoidosis: identification of key players and risk modifiers

DOI: 10.5114/aoms.2018.79682

Year: 2019

SAT0304 RELATIONSHIP BETWEEN INTERLEUKIN-23 AND GASTROINTESTINAL INVOLVEMENT IN PATIENTS WITH SYSTEMIC SCLEROSIS

DOI: 10.1136/annrheumdis-2019-eular.2289

Year: 2019

Genetic characterization of GSD I in Serbian population revealed unexpectedly high incidence of GSD Ib and 3 novel SLC37A4 variants

DOI: 10.1111/cge.13093

Year: 2018

Association between the -174 C/G polymorphism in the interleukin-6 (IL-6) gene and gastrointestinal involvement in patients with systemic sclerosis

DOI: 10.1007/s10067-018-4163-6

Year: 2018

The use of canine mesenchymal stem cells for the autologous treatment of osteoarthritis.

DOI: 10.1556/004.2018.034

Year: 2018

Genomic profiling supports the diagnosis of primary ciliary dyskinesia and reveals novel candidate genes and genetic variants

DOI: 10.1371/journal.pone.0205422

Year: 2018

What is the Role of Epigenetics?

How Are Translocations Diagnosed?

What are the Limitations and Challenges?

What are Biological Agents that Induce Mutations?

What Are the Types of Phylogenetic Trees?

How is Cystic Fibrosis Inherited?

What are the Latest Diagnostic Tools?

What is Genetic Engineering?

How Do CFTR Gene Mutations Cause Disease?

What is Pharmacogenomics?

Partnered Content Networks

Relevant Topics